ArticleOncotarget2016

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.

Jia-Jia Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.